
Capital manager Blackrock has increased its holding in Novo Nordisk to 5.07 percent of the entire share capital, Novo Nordisk reports in a shareholder announcement on Monday.
Blackrock is now a major shareholder of the pharmaceutical giant with a block of shares of over 5 percent. However, the capital manager still only has below 5 percent of voting rights, the release states.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app